← Back to directory

Laurence Zitvogel

Researcher Next ID · RN-024968

Researcher · Medicine

Inserm

Paris, France

Not currently recruitingFunding unknown
Works count
1,176
Citation count
157,411
H-index
168
i10-index
550

Research interests

Medicine
Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Immune Cell Function and Interaction
CAR-T cell therapy research
Gut microbiota and health

Publications

  • Immunogenic cell stress and death

    Nature Immunology · 2022 · 10.1038/s41590-022-01132-2

  • Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease

    Immunity · 2021 · https://doi.org/10.1016/j.immuni.2021.07.007

  • The microbiome and human cancer

    Science · 2021 · https://doi.org/10.1126/science.abc4552

  • Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

    Nature Reviews Clinical Oncology · 2020 · 10.1038/s41571-020-0413-z

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000337

  • Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

    Cell · 2020 · https://doi.org/10.1016/j.cell.2020.08.002

  • Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Science · 2017 · https://doi.org/10.1126/science.aan3706

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Science · 2017 · https://doi.org/10.1126/science.aan4236

  • The immune contexture in cancer prognosis and treatment

    Nature Reviews Clinical Oncology · 2017 · 10.1038/nrclinonc.2017.101

  • Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

    Annals of Oncology · 2016 · 10.1093/annonc/mdw168

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Immunity · 2016 · 10.1016/j.immuni.2015.11.024

  • Immunogenic cell death in cancer and infectious disease

    Nature reviews. Immunology · 2016 · 10.1038/nri.2016.107

  • Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

    Cancer Cell · 2015 · 10.1016/j.ccell.2015.10.012

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Science · 2015 · https://doi.org/10.1126/science.aad1329

  • Type I interferons in anticancer immunity

    Nature reviews. Immunology · 2015 · 10.1038/nri3845

  • Consensus guidelines for the detection of immunogenic cell death

    OncoImmunology · 2014 · 10.4161/21624011.2014.955691

  • The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

    Science · 2013 · 10.1126/science.1240537

  • Immunogenic Cell Death in Cancer Therapy

    Annual Review of Immunology · 2012 · https://doi.org/10.1146/annurev-immunol-032712-100008

  • Innate or Adaptive Immunity? The Example of Natural Killer Cells

    Science · 2011 · 10.1126/science.1198687

  • Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

    Science · 2011 · 10.1126/science.1208347

  • Immunogenic and tolerogenic cell death

    Nature reviews. Immunology · 2009 · 10.1038/nri2545

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    Nature Medicine · 2009 · 10.1038/nm.2028

  • Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

    Nature Medicine · 2007 · 10.1038/nm1622

  • Immunological aspects of cancer chemotherapy

    Nature reviews. Immunology · 2007 · 10.1038/nri2216

  • Cancer despite immunosurveillance: immunoselection and immunosubversion

    Nature reviews. Immunology · 2006 · 10.1038/nri1936

  • Calreticulin exposure dictates the immunogenicity of cancer cell death

    Nature Medicine · 2006 · 10.1038/nm1523

  • CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

    The Journal of Experimental Medicine · 2005 · 10.1084/jem.20051511

  • Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

    The Journal of Experimental Medicine · 2005 · 10.1084/jem.20050915

  • Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

    Journal of Translational Medicine · 2005 · 10.1186/1479-5876-3-10

  • Antigen Presentation and T Cell Stimulation by Dendritic Cells

    Annual Review of Immunology · 2002 · 10.1146/annurev.immunol.20.100301.064828

  • Exosomes: composition, biogenesis and function

    Nature reviews. Immunology · 2002 · https://doi.org/10.1038/nri855

  • Malignant effusions and immunogenic tumour-derived exosomes

    The Lancet · 2002 · 10.1016/s0140-6736(02)09552-1

  • Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

    Nature Medicine · 2001 · 10.1038/85438

  • Molecular Characterization of Dendritic Cell-Derived Exosomes

    The Journal of Cell Biology · 1999 · 10.1083/jcb.147.3.599

  • Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes

    Nature Medicine · 1998 · 10.1038/nm0598-594

Current projects

    No projects listed.